Investors Research Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Investors Research Corp’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21	Closed	-$2.68K	–	894
2026 Q1	$2.68K	Hold	21	–	–	﹤0.01%	674
2025 Q4	$2.56K	Sell	21 -200	-90%	-$22.9K	﹤0.01%	743
2025 Q3	$22.1K	Hold	221	–	–	﹤0.01%	544
2025 Q2	$18.3K	Buy	221 +200	+952%	+$16K	﹤0.01%	603
2025 Q1	$1.7K	Hold	21	–	–	﹤0.01%	870
2024 Q4	$1.89K	Hold	21	–	–	﹤0.01%	853
2024 Q3	$2.08K	Hold	21	–	–	﹤0.01%	884
2024 Q2	$1.95K	Buy	+21	New	+$1.88K	﹤0.01%	942
2024 Q1	–	Sell	-67	Closed	-$5.98K	–	1098
2023 Q4	$5.98K	Hold	67	–	–	﹤0.01%	802
2023 Q3	$4.89K	Hold	67	–	–	﹤0.01%	831
2023 Q2	$5.57K	Hold	67	–	–	﹤0.01%	845
2023 Q1	$5.11K	Hold	67	–	–	﹤0.01%	873
2022 Q4	$5.56K	Hold	67	–	–	﹤0.01%	863
2022 Q3	$5K	Buy	+67	New	+$5.65K	﹤0.01%	870

Other funds holding XBI

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

PSP Research Newtown Square, Pennsylvania $188M AUM

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

MFS

Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

LHWM

Lake Hills Wealth Management Austin, Texas $220M AUM 39.11% 1-Year Est. Return

MWA

MFA Wealth Advisors Pittsburgh, Pennsylvania $587M AUM 27.44% 1-Year Est. Return

Investors Research Corp's XBI Position: Q2 2026 in Review

Investors Research Corp sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 21 shares — an estimated $2.68K sold.

Investors Research Corp first reported a position in XBI in Q3 2022 and held it in 14 quarters. The position peaked at $22.1K in Q3 2025. 154 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Investors Research Corp reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
Investors Research Corp sold 21 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.68K.
Investors Research Corp first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and held it in 14 quarters.
Investors Research Corp's State Street SPDR S&P Biotech ETF position peaked at $22.1K in Q3 2025.
154 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.